Profitability
Weight: 20%
F
0
- 5yr Avg ROIC -20.4%
ELVN
Enliven Therapeutics, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 18.1 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -25.9%
- 5yr Share-Count CAGR 66.8%
Growth Quality
Weight: 15%
F
0
- Revenue-Growth Years (5) 0/5
Cash Generation
Weight: 15%
F
14
- 5yr FCF Margin 0.0%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 20%
C
55
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 148.44
Stability
Weight: 15%
D
33
- Piotroski F-Score 3
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 2 gurus held; 1 added; 2 full exits.
- Holders
- 1 -1
- Avg Δ position
- +58.0%
- New buys
- 0
- Full exits
- 2
- Druckenmiller sold -100%
- Wood sold -100%
- Cooperman increased +58%